Dominique Demolle, PhD profile page

Dr. Dominique Demolle is the co-founder and chief executive officer of Cognivia, a company leveraging machine learning and patient psychology to reduce data variability and improve the conduct of clinical trials. With decades of experience in clinical development, including her role as associate director of Global Early Phase Operations at Eli Lilly and her efforts to build partnerships with pharmaceutical and biotech companies, Demolle has demonstrated the importance of understanding patient behavior in drug development. Her commitment to developing innovative technologies aims to prevent therapy failures caused by treatment nonadherence, dropout, patient heterogeneity, and placebo response. Demolle earned her PhD in biochemistry from the University of Brussels. Demolle was honored as one of the Most Inspiring People in Life Sciences by the 2022 PharmaVoice 100 awards and was named among the Top Women Leaders in Healthcare Technology in 2025. Cognivia was recognized among the Top 50 Healthcare Technology Companies of 2025. The company’s predictive AI platform, Placebell, was selected as a finalist for the Fierce Life Science Innovation Award in 2025.